-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 CHt6B/fNhcaidZUZwpfKNPn7hCM5bQzQ2jFE/i1w6deYJ4GOGIpHcPczcyxGUaE4
 x6imqb2pP+a2mrXDNWMdDg==

<SEC-DOCUMENT>0000069499-06-000008.txt : 20060217
<SEC-HEADER>0000069499-06-000008.hdr.sgml : 20060217
<ACCEPTANCE-DATETIME>20060217180044
ACCESSION NUMBER:		0000069499-06-000008
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20060215
FILED AS OF DATE:		20060217
DATE AS OF CHANGE:		20060217

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MYLAN LABORATORIES INC
		CENTRAL INDEX KEY:			0000069499
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				251211621
		STATE OF INCORPORATION:			PA
		FISCAL YEAR END:			0331

	BUSINESS ADDRESS:	
		STREET 1:		1500 CORPORATE DRIVE
		STREET 2:		SUITE 400
		CITY:			CANONSBURG
		STATE:			PA
		ZIP:			15317
		BUSINESS PHONE:		724-514-1800

	MAIL ADDRESS:	
		STREET 1:		1500 CORPORATE DRIVE
		STREET 2:		SUITE 400
		CITY:			CANONSBURG
		STATE:			PA
		ZIP:			15317

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	FRM CORP
		DATE OF NAME CHANGE:	19711003

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			KORMAN HARRY
		CENTRAL INDEX KEY:			0001197548

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-09114
		FILM NUMBER:		06630484

	MAIL ADDRESS:	
		STREET 1:		MYLAN LABORATORIES INC
		STREET 2:		1718 NORTHROCK CT
		CITY:			ROCKFORD
		STATE:			IL
		ZIP:			61103
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>primary_doc.xml
<DESCRIPTION>PRIMARY DOCUMENT
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0202</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2006-02-15</periodOfReport>

    <notSubjectToSection16>0</notSubjectToSection16>

    <issuer>
        <issuerCik>0000069499</issuerCik>
        <issuerName>MYLAN LABORATORIES INC</issuerName>
        <issuerTradingSymbol>MYL</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001197548</rptOwnerCik>
            <rptOwnerName>KORMAN HARRY</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>781 CHESTNUT RIDGE RD.</rptOwnerStreet1>
            <rptOwnerStreet2></rptOwnerStreet2>
            <rptOwnerCity>MORGANTOWN</rptOwnerCity>
            <rptOwnerState>WV</rptOwnerState>
            <rptOwnerZipCode>26505</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>1</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle>Pres., Mylan Pharmaceuticals</officerTitle>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>Mylan Laboratories Inc. Common Stock</value>
                <footnoteId id="F1"/>
            </securityTitle>
            <transactionDate>
                <value>2006-02-15</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>A</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionTimeliness>
                <value></value>
            </transactionTimeliness>
            <transactionAmounts>
                <transactionShares>
                    <value>13298</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>0</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>16748</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
    </nonDerivativeTable>

    <footnotes>
        <footnote id="F1">The reporting person was granted restricted stock pursuant to the Mylan Laboratories Inc. 2003 Long-Term Incentive Plan.  The shares vest in three equal installments, beginning February 14, 2007.  Mylan Laboratories Inc. common stock Indirect ownership through 401(k) holdings was 921 shares as of February 15, 2006.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>/s/ Harry A. Korman</signatureName>
        <signatureDate>2006-02-17</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----